Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Tumor necrosis factor-α impairs oligodendroglial differentiation through a mitochondria-dependent process.
Circulating innate lymphoid cells are unchanged in response to DAC HYP therapy.
Headache in relapse and remission phases of multiple sclerosis: A case-control study.
Use of interleukin-2 for management of natalizumab-associated progressive multifocal leukoencephalopathy: case report and review of literature.
Synaptic pathology: a shared mechanism in neurological disease.
Headwaters of the zebrafish -- emergence of a new model vertebrate.
A comparison of phase imaging and quantitative susceptibility mapping in the imaging of multiple sclerosis lesions at ultrahigh field.
Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis.
CSF levels of YKL-40 are increased in MS and replaces with immunosuppressive treatment.
Testing the measurement invariance of the University of Washington Self-Efficacy Scale short form across four diagnostic subgroups.
Our Products (page shows "Copaxone" as a trade name for glatiramer acetate)
Genpharm and Genzyme Aubagio ® agreement for the MENA region
Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis.
Multiple sclerosis: Mitoxantrone promotes differential effects on immunocompetent cells in vitro.
Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trial.
Maternal and perinatal outcomes in pregnancies with multiple sclerosis: a case-control study.
Regulation of B cell function by the immunosuppressive agent leflunomide.
Vision Disturbances in Multiple Sclerosis.
Magnetization transfer ratio in the delayed-release dimethyl fumarate DEFINE study.
Beneficial actions of the anti-inflammatory dimethyl fumarate in glioblastomas.
Biogen Idec reports death of patient on its MS pill
Interferon-β1a protects neurons against mitochondrial toxicity via modulation of STAT1 signaling: Electrophysiological evidence.
Bioengineered cell culture systems of central nervous system injury and disease.
Ethnicity and prevalence of multiple sclerosis in east London.
A Complex Case of Neuro-Behçet's Disease in a Patient Previously Diagnosed with multiple Sclerosis: A Case Report.
Pages
« first
‹ previous
…
47
48
49
50
51
52
53
54
55
…
next ›
last »